Dai-ichi Life Insurance Company’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.27M Buy
16,832
+246
+1% +$134K 0.24% 93
2025
Q4
$9.61M Sell
16,586
-1,546
-9% -$874K 0.25% 84
2025
Q3
$8.79M Buy
18,132
+2,438
+16% +$1.13M 0.22% 99
2025
Q2
$6.36M Sell
15,694
-2,215
-12% -$926K 0.18% 122
2025
Q1
$8.91M Buy
17,909
+7,152
+66% +$3.87M 0.26% 93
2024
Q4
$5.6M Sell
10,757
-6,950
-39% -$3.82M 0.15% 148
2024
Q3
$11M Buy
17,707
+168
+1% +$99.4K 0.28% 88
2024
Q2
$9.7M Sell
17,539
-1,285
-7% -$736K 0.24% 104
2024
Q1
$10.9M Sell
18,824
-349
-2% -$196K 0.25% 94
2023
Q4
$10.2M Sell
19,173
-13,374
-41% -$6.47M 0.21% 102
2023
Q3
$16.5M Buy
32,547
+8,497
+35% +$4.53M 0.36% 59
2023
Q2
$12.5M Sell
24,050
-6,552
-21% -$3.54M 0.26% 78
2023
Q1
$17.6M Buy
30,602
+429
+1% +$242K 0.39% 59
2022
Q4
$16.6M Sell
30,173
-13,544
-31% -$7.18M 0.38% 53
2022
Q3
$22.2M Buy
43,717
+5,208
+14% +$2.91M 0.55% 36
2022
Q2
$20.9M Sell
38,509
-6,413
-14% -$3.53M 0.47% 46
2022
Q1
$26.5M Sell
44,922
-3,190
-7% -$1.83M 0.42% 57
2021
Q4
$32.1M Sell
48,112
-2,167
-4% -$1.35M 0.41% 46
2021
Q3
$28.7M Sell
50,279
-971
-2% -$533K 0.37% 48
2021
Q2
$25.9M Buy
51,250
+2,781
+6% +$1.31M 0.32% 58
2021
Q1
$22.1M Sell
48,469
-688
-1% -$328K 0.3% 57
2020
Q4
$22.9M Buy
49,157
+7,850
+19% +$3.68M 0.33% 51
2020
Q3
$18.2M Buy
41,307
+5,126
+14% +$2.12M 0.33% 55
2020
Q2
$13.1M Sell
36,181
-4,420
-11% -$1.48M 0.3% 61
2020
Q1
$11.5M Sell
40,601
-1,396
-3% -$440K 0.44% 55
2019
Q4
$13.6M Buy
41,997
+5,319
+15% +$1.61M 0.31% 74
2019
Q3
$10.7M Sell
36,678
-7,132
-16% -$2.04M 0.26% 88
2019
Q2
$12.9M Buy
43,810
+7,132
+19% +$1.96M 0.31% 81
2019
Q1
$10M Sell
36,678
-8,866
-19% -$2.21M 0.25% 100
2018
Q4
$10.2M Sell
45,544
-1,356
-3% -$318K 0.28% 92
2018
Q3
$11.4M Sell
46,900
-7,966
-15% -$1.83M 0.25% 102
2018
Q2
$11.4M Sell
54,866
-6,469
-11% -$1.37M 0.27% 88
2018
Q1
$12.7M Buy
61,335
+8,301
+16% +$1.74M 0.26% 84
2017
Q4
$10.1M Sell
53,034
-383
-0.7% -$73.4K 0.2% 101
2017
Q3
$10.1M Sell
53,417
-6,000
-10% -$1.09M 0.21% 94
2017
Q2
$10.4M Buy
59,417
+2,602
+5% +$437K 0.23% 94
2017
Q1
$8.73M Buy
56,815
+40,000
+238% +$6.11M 0.24% 104
2016
Q4
$2.37M Buy
+16,815
New +$2.48M 0.07% 278

Other funds holding TMO

Dai-ichi Life Insurance Company's TMO Position: Q1 2026 in Review

Dai-ichi Life Insurance Company increased its Thermo Fisher Scientific (TMO) stake by 1.5% in Q1 2026, buying an estimated $134K and bringing the position to 16,832 shares worth $8.27M. The position accounts for 0.24% of the portfolio, ranked #93.

Dai-ichi Life Insurance Company first reported a position in TMO in Q4 2016 and has held it in 38 quarters since. The position peaked at $32.1M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Dai-ichi Life Insurance Company held 16,832 shares of Thermo Fisher Scientific worth $8.27M as of Q1 2026.
  • Dai-ichi Life Insurance Company bought 246 Thermo Fisher Scientific shares in Q1 2026, an estimated $134K.
  • Thermo Fisher Scientific made up 0.24% of Dai-ichi Life Insurance Company's portfolio in Q1 2026, its #93 holding.
  • Dai-ichi Life Insurance Company first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 38 quarters since.
  • Dai-ichi Life Insurance Company's Thermo Fisher Scientific position peaked at $32.1M in Q4 2021.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Dai-ichi Life Insurance Company's 13F filing for Q1 2026, filed 14 May 2026.